Document is current
Any future updates will be listed below
-
Authors
Knoerl, Robert https://orcid.org/0000-0002-6996-5068
Berry, Donna L.
Meyerhardt, Jeffrey
Reyes, Kaitlen
Salehi, Elahe
Gewandter, Jennifer S.
-
Funding
Funding for this research was provided by:
Rita and Alex Hillman Foundation
- License Information
-
More Information
Article History
Accepted: 20 July 2022
First Online: 5 August 2022
Declarations
:
: Approval was obtained from the Dana-Farber Cancer Institute Office of Human Research Studies (19–535). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: RK has received personal fees (consulting) from Strategy Inc., Spark Healthcare, and the Comprehensive and Integrative Medicine Institute and serves on the scientific advisory board of Wellium. JM has served as an advisor/consultant to Merck Pharmaceutical and COTA Healthcare. JG has received grant funding from the National Institutes of Health, compensation for grant reviews from the US Department of Defense, and consulting income from Algo Therapeutix, Asahi Kasei Pharma, Eikonizo Therapeutics, GW Pharma, Magnolia Neurosciences, Orthogonal Neurosciences, Science Branding Communications, SK Life Science, and Saluda Medical.
